PT Famon Awal Bros Sedaya Tbk

PT Famon Awal Bros Sedaya Tbk

IIDX:PRAY
715.00
IDR
+10.00
(+1.42%)
10.88EPS
60.75P/E
9.14TMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
72.71
95.83
130.81
116.73
131.76
150.65
174.57
191.41
Basic EPS, GAAP
8.75
20.22
23.35
4.79
15.54
14.43
15.15
10.78
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
7.7
- -
- -
- -
- -
Book Value per Share
83.23
106.11
130.44
185.4
200.48
215.43
231.54
235.79
Tangible Book Value per Share
83.23
106.11
130.07
184.94
200
214.9
213.68
217.82
Basic Weighted Avg Shares
13,959
13,959
13,959
13,043
13,959
13,959
13,959
13,959
Sales/Revenue/Turnover
1,014,975
1,337,747
1,826,014
1,522,624
1,839,233
2,103,055
2,436,837
2,671,957
Operating Margin (%)
17.67
29.08
30.65
7.79
11.42
12.25
11.19
9.93
Depreciation Expense
723
560
412
331
3,464
6,754
6,819
9,178
Net Income, GAAP
122,204
282,215
325,959
62,503
216,974
201,443
211,428
150,519
Effective Tax Rate (%)
23.86
20.43
24.75
21.6
16.28
26.19
26.77
35.6
Profit Margin (%)
12.04
21.1
17.85
4.1
11.8
9.58
8.68
5.63
Working Capital
323,187
510,513
807,286
1,278,474
1,212,305
1,161,220
615,842
582,066
LT Debt
415,931
530,604
815,993
815,888
1,181,794
1,270,387
1,584,853
1,675,578
Total Equity
1,184,151
1,507,818
1,855,830
2,706,972
2,934,577
3,134,137
3,465,925
3,522,668
Return on Invested Capital (%)
- -
16.15
16.93
2.74
4.38
4.38
3.98
3.45
Return on Capital (%)
- -
16.02
14.47
3.98
7.11
5.99
5.43
4.3
Return on Common Equity (%)
- -
22.48
20.78
2.89
8.06
6.94
6.78
4.99

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
347,228
318,985
311,929
LT Borrowings
1,414,308
1,392,822
1,505,287
LT Finance Leases
170,545
170,563
170,291
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13,959
13,959
13,959
Market Capitalization
12,423,886
9,911,190
9,143,422

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,569,905
1,506,358
1,538,252
Cash, Cash Equivalents & STI
735,870
597,617
567,532
Accounts Receivable, Net
548,469
605,118
635,392
Inventories
77,712
72,436
81,872
Total Current Liabilities
954,063
968,822
956,186
Payables & Accruals
- -
- -
- -
ST Debt
347,228
318,985
311,929
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
18.95%
10.59%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
35.92%
4.96%
Sales/Revenue/Turnover
- -
14.18%
15.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
520,417
503,778
530,079
548,781
2,103,055
2025
548,832
551,479
- -
687,795
2,436,837
2026
686,687
745,996
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5.8
4.62
5.09
-1.09
14.43
2025
2.98
3.13
- -
3.46
15.15
2026
1.53
2.67
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Arfan Awaloeddin
Full Time Employees
6,473
Sector
Health services
Industry
Hospital/Nursing management
Address
Jl. Ruko Mega Grosir Cempaka Mas Blok N/21 Jakarta Pusat Indonesia 10640
IPO Date
Nov 8, 2022
Business
PT Famon Awal Bros Sedaya Tbk operates as a holding company for Primaya Hospital Group, Indonesia's private hospital network targeting mid- to upper-class markets with comprehensive healthcare services; core offerings include centers of excellence for cardiac and vascular care, trauma, cancer and oncology, urology, brain and neuro, maternal and child health, eye care, and orthopedic sports clinics, alongside clinical laboratory services, homecare, medical evacuation, and online consultations. The company manages 20 hospitals with over 3,000 beds across Java, Sumatra, Kalimantan, and Sulawesi, supported by more than 1,100 specialist doctors, 2,800 nurses and midwives, and 800 medical support staff. Founded in 1997 and headquartered in Jakarta, Indonesia, it listed on the Indonesia Stock Exchange in November 2022 under ticker PRAY.JK and holds national KARS accreditation plus JCI international accreditation for two facilities. Recent expansions feature aggressive hospital development with up to IDR 900 billion in 2025 capex, targeting a new Primaya Hospital operational by year-end 2025 and construction completion for another, alongside plans for new hospitals, acquisitions, or clinic integrations to drive synergy; it earned recognition as one of Indonesia's Best Managed Companies in 2025.